biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by roadking08on Jul 31, 2016 10:38pm

123 Views

Post# 25099811

RE:It's a good thing you can't trade experience....Though

I must apologize jd, after reading my post from Friday night, while after having a few I was a bit ticked that you posted you were leaving the board for elsewhere, I had no reason to single you out to reading the book " market wizards".
the whole last week, I just keep banging my head for not conserving any capital,to reload sufficiently.as market wizards suggest.
Now, As I said in the past, where's the missing link of a pp?.
rk

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta